Variations in Physiological, Psychomotor, and Analgesic Parameters during Titration of Nitrous Oxide in 3-12 Years

Shivangi Sharma1, Radhika Chopra1, Shivani Mathur1

  • 1Department of Pedodontics and Preventive Dentistry, ITS Centre for Dental Studies and Research, Muradnagar, Uttar Pradesh, India.

Insights

Nitrous oxide (N₂O) effectively reduced pain and increased oxygen saturation in children aged 3-12. However, it significantly impacted psychomotor abilities, with no correlation found between physiological and analgesic parameters.

Area of Science:

  • Pediatric Dentistry
  • Anesthesiology
  • Pain Management

Background:

  • Assessing physiological, psychomotor, and analgesic effects of nitrous oxide-oxygen (N₂O) inhalation sedation in children aged 3-12 years.
  • Evaluating variations at different N₂O concentrations (0-50%) and 100% oxygen.

Discussion:

  • Nitrous oxide titration significantly increased oxygen saturation (SpO₂) and decreased heart rate (HR) at 50% concentration.
  • Pain scores significantly reduced at 40% and 50% N₂O levels, indicating effective analgesia.
  • Respiratory rate remained stable, but psychomotor abilities were consistently affected across all N₂O concentrations.

Key Insights:

  • Nitrous oxide is effective for pain relief and improving oxygenation in pediatric dental patients.
  • Significant psychomotor impairment necessitates careful consideration during and after N₂O administration.
  • No direct correlation was observed between physiological changes, pain reduction, and psychomotor effects.

Outlook:

  • Further research could explore strategies to mitigate psychomotor effects of N₂O in pediatric sedation.
  • Investigating alternative or adjunctive sedation techniques for children requiring dental procedures.
  • Long-term follow-up studies on the psychomotor development of children undergoing repeated N₂O sedation.
Abstract

Related Concept Videos

Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
646
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
1.0K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
376
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
53